Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country.

Fernández-Villegas A, Thomas MC, Carrilero B, Téllez C, Marañón C, Murcia L, Moralo S, Alonso C, Segovia M, López MC.

Acta Trop. 2014 Aug 19;140C:84-90. doi: 10.1016/j.actatropica.2014.08.006. [Epub ahead of print]

PMID:
25149352
[PubMed - as supplied by publisher]
2.

Benznidazole treatment reduces the induction of indoleamine 2,3-dioxygenase (IDO) enzymatic activity in Chagas disease symptomatic patients.

Marañón C, Egui A, Fernández-Villegas A, Carrilero B, Thomas MC, Segovia M, López MC.

Parasite Immunol. 2013 May-Jun;35(5-6):180-7. doi: 10.1111/pim.12030.

PMID:
23473453
[PubMed - indexed for MEDLINE]
3.

Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology.

Thomas MC, Fernández-Villegas A, Carrilero B, Marañón C, Saura D, Noya O, Segovia M, Alarcón de Noya B, Alonso C, López MC.

Clin Vaccine Immunol. 2012 Feb;19(2):167-73. doi: 10.1128/CVI.05566-11. Epub 2011 Dec 7.

PMID:
22155766
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Short-term follow-up of chagasic patients after benzonidazole treatment using multiple serological markers.

Fernández-Villegas A, Pinazo MJ, Marañón C, Thomas MC, Posada E, Carrilero B, Segovia M, Gascon J, López MC.

BMC Infect Dis. 2011 Jul 31;11:206. doi: 10.1186/1471-2334-11-206.

PMID:
21801456
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk